HER2-targeting PBX-7 antibody-drug conjugates (Pinotbio)

N/A

Report date: 2025/06/11 10:46:42

Base Information

Drug NameHER2-targeting PBX-7 antibody-drug conjugates (Pinotbio)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionDNA topoisomerase I inhibitorsReceptor protein-tyrosine kinase erbB-2 modulatorsApoptosis stimulants

TargetsReceptor protein-tyrosine kinase erbB-2DNA topoisomerase I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPinotbio Inc

China Registration ClassN/A

Active CompaniesPinotbio Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A